PMID- 24189016 OWN - NLM STAT- MEDLINE DCOM- 20140127 LR - 20161128 IS - 1535-3699 (Electronic) IS - 1535-3699 (Linking) VI - 238 IP - 12 DP - 2013 Dec TI - Normobaric, intermittent hypoxia conditioning is cardio- and vasoprotective in rats. PG - 1413-20 LID - 10.1177/1535370213508718 [doi] AB - Favorable versus detrimental cardiovascular responses to intermittent hypoxia conditioning (IHC) are heavily dependent on experimental or pathological conditions, including the duration, frequency and intensity of the hypoxia exposures. Recently, we demonstrated that a program of moderate, normobaric IHC (FIO2 9.5-10% for 5-10 min/cycle, with intervening 4 min normoxia, 5-8 cycles/day for 20 days) in dogs afforded robust cardioprotection against infarction and arrhythmias induced by coronary artery occlusion-reperfusion, but this protection has not been verified in other species. Accordingly, in this investigation cardio- as well as vasoprotection were examined in male Wistar rats completing the normobaric IHC program or a sham program in which the rats continuously breathed atmospheric air. Myocardial ischemia and reperfusion (IR) was imposed by occlusion and reperfusion of the left anterior descending coronary artery in in situ experiments and by subjecting isolated, perfused hearts to global ischemia-reperfusion. Cardiac arrhythmias and myocardial infarct size were quantified in in situ experiments. Endothelial function was evaluated from the relaxation to acetylcholine of norepinephrine-precontracted aortic rings taken from in situ IR experiments, and from the increase in coronary flow produced by acetylcholine in isolated hearts. IHC sharply reduced cardiac arrhythmias during ischemia and decreased infarct size by 43% following IR. Endothelial dysfunction in aorta was marked after IR in sham rats, but not significant in IHC rats. Similar findings were found for the coronary circulations of isolated hearts. These findings support the hypothesis that moderate, normobaric IHC is cardio- and vasoprotective in a rat model of IR. FAU - Manukhina, Eugenia B AU - Manukhina EB AD - Laboratory of Adaptation, Institute for General Pathology and Pathophysiology, Moscow 125315, Russian Federation. FAU - Belkina, Ludmila M AU - Belkina LM FAU - Terekhina, Olga L AU - Terekhina OL FAU - Abramochkin, Denis V AU - Abramochkin DV FAU - Smirnova, Elena A AU - Smirnova EA FAU - Budanova, Olga P AU - Budanova OP FAU - Mallet, Robert T AU - Mallet RT FAU - Downey, H Fred AU - Downey HF LA - eng GR - R01NS076975/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20131104 PL - Switzerland TA - Exp Biol Med (Maywood) JT - Experimental biology and medicine (Maywood, N.J.) JID - 100973463 SB - IM MH - Animals MH - Aorta/physiology/physiopathology MH - Arrhythmias, Cardiac/physiopathology/prevention & control MH - *Cardiovascular Physiological Phenomena MH - Cardiovascular System/physiopathology MH - Endothelium, Vascular/physiology/physiopathology MH - Hypoxia/*physiopathology MH - Ischemic Preconditioning, Myocardial/*methods MH - Male MH - Myocardial Ischemia/physiopathology/prevention & control MH - Myocardial Reperfusion MH - Myocardial Reperfusion Injury/physiopathology/prevention & control MH - Rats MH - Rats, Wistar OTO - NOTNLM OT - Acetylcholine OT - aorta OT - coronary circulation OT - myocardial infarction OT - myocardial ischemia and reperfusion OT - nitric oxide EDAT- 2013/11/06 06:00 MHDA- 2014/01/28 06:00 CRDT- 2013/11/06 06:00 PHST- 2013/11/06 06:00 [entrez] PHST- 2013/11/06 06:00 [pubmed] PHST- 2014/01/28 06:00 [medline] AID - 1535370213508718 [pii] AID - 10.1177/1535370213508718 [doi] PST - ppublish SO - Exp Biol Med (Maywood). 2013 Dec;238(12):1413-20. doi: 10.1177/1535370213508718. Epub 2013 Nov 4.